BioLoomics
Business Services · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4665 Nautilus Ct S Unit 1, Boulder, Colo...Phone Number
(303) 955-2982Website
www.bioloomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioLoomics
Bioloomics is engaged in advanced laboratory research, focusing on the development of Super-ADCs (Antibody-Drug Conjugates). The company is dedicated to innovative programs such as Directed Evolution. Their services are aimed at clients in the biotechnology and pharmaceutical sectors. Bioloomics emphasizes the importance of privacy and user experience on their website.Explore more
BioLoomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioLoomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BioLoomics has new funding data
BioLoomics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when BioLoomics launches new products
Check if BioLoomics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at BioLoomics
Click to see if BioLoomics had a recent Job posting/layoffs
Earning: See what the market has to say on BioLoomics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if BioLoomics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to BioLoomics
Compare insights from companies similar to BioLoomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioLoomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioLoomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioLoomics.
BioLoomics financials insights
Gather financial insights about BioLoomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$8.7M
BioLoomics Tech Stack
A closer look at the technologies used by BioLoomics
See more technologies
BioLoomics News & Media
BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs
BOULDER, Colo.--(BUSINESS WIRE)--BioLoomics, a biotechnology company that targets peptide-antibody chimeras to specific compartments inside of diseased cells, announced today that Kurt Gish, Ph.D., has joined as the Chief Scientific Officer. Dr Gish will focus on building the company’s pipeline of lysosomal targeting ADCs in oncology to overcome the limitations of poor tumor uptake, which hinders safety and efficacy across the ADC market. “Kurt is an impressive and accomplished scientist that sBioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
BOULDER, Colo.--(BUSINESS WIRE)--BioLoomics, the company pioneering directed evolution of target degrading antibodies using human cells, today announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs. The round was led by Innovation Endeavors, with participation from Horizons Ventures, TechU Ventures, Boom Capital Ventures, Hummingbird Nomads Fund, Cooley GC&H, BoxOne Ventures and Viswa Colluru (Founder of Enveda).
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioLoomics
Sign Up For FreeTo access detailed company insights
Bioloomics is engaged in advanced laboratory research, focusing on the development of Super-ADCs (Antibody-Drug Conjugates). The company is dedicated to innovative programs such as Directed Evolution. Their services are aimed at clients in the biotechnology and pharmaceutical sectors. Bioloomics emphasizes the importance of privacy and user experie... Read More
